======= IFNL2 ======= == Gene Information == * **Official Symbol**: IFNL2 * **Official Name**: interferon lambda 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=282616|282616]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8IZJ0|Q8IZJ0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IFNL2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IFNL2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607401|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Cytokine with antiviral, antitumour and immunomodulatory activities. Plays a critical role in the antiviral host defense, predominantly in the epithelial tissues. Acts as a ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1, and receptor engagement leads to the activation of the JAK/STAT signaling pathway resulting in the expression of IFN- stimulated genes (ISG), which mediate the antiviral state. Has a restricted receptor distribution and therefore restricted targets: is primarily active in epithelial cells and this cell type- selective action is because of the epithelial cell-specific expression of its receptor IFNLR1. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium. Exerts an immunomodulatory effect by up-regulating MHC class I antigen expression. {ECO:0000269|PubMed:12469119, ECO:0000269|PubMed:12483210, ECO:0000269|PubMed:16539846}. No Pfam Domain information is available for this gene. |mucosal immune response| |organ or tissue specific immune response| |receptor signaling pathway via JAK-STAT| |receptor signaling pathway via STAT| |cytokine activity| |defense response to virus| |response to virus| |signaling receptor binding| |cytokine-mediated signaling pathway| |innate immune response| |positive regulation of immune response| |defense response to other organism| |cellular response to cytokine stimulus| |immune effector process| |response to cytokine| |positive regulation of immune system process| |regulation of immune response| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |extracellular space| |regulation of immune system process| |immune response| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp285|GW501516 25μM R06 exp285]]|-1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13313 * **Expression level (log2 read counts)**: -6.6 {{:chemogenomics:nalm6 dist.png?nolink |}}